ArticleOncology letters2018

Colon cancers carrying BRAF V600E and β-catenin T41A activating mutations are resistant to numerous common anticancer drugs.

Guangzhong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.